End Drug Shortages Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 10239.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. SPANBERGER, as printed in the Congressional Record (Vol. 170, No. 173, November 21, 2024, Page H6193):
  Article I, Section 8 The single subject of this legislation is: To amend the Federal Food, Drug, and Cosmetic Act to expand drug shortage notification practices to include surges in demand for a drug, and for other purposes.
  Source: Congress.gov, Congressional Record November 21, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  224 characters

  Congress.gov bill record

  H.R. 10239, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/10239

  Record last updated by Congress.gov

  January 9, 2026

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  d0a8e877bd98cff4e6b7792fc9931d46a36374e44c4dee1471a9da31fd8560c6

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of January 9, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 10239, last updated January 9, 2026. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.